One of the reasons why Florida is one of the leaders in clinical trial providers is because of the population of this state. The disease population, the elderly, but also healthy volunteers. Florida is No. 2 in the nation for clinical trial providers. Another area of expertise in the South Florida region is RNA technology […]
Sensus Healthcare to Present at the 31st Annual ROTH Conference
BOCA RATON, Fla., March 13, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19 at 3:30 p.m. […]
Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians
New Online Portal System to Offer Training and Education Related to SRT Devices and Technology BOCA RATON, Fla., March 12, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today the launch of SRT University, an online portal to support […]
Technology Networks: Superficial Radio Therapy: A non-surgical Treatment for Non-melanoma Skin Cancers
Skin cancer can be broadly split in to two types: melanoma and non-melanoma. The most common non-melanomas include basal cell carcinoma and squamous cell carcinoma, for which the main treatment is surgery. However, other non-surgical options are emerging, including superficial radiation therapy (SRT), a unique type of photon radiotherapy. To learn more about SRT we […]
Thrive Global – The Future of Healthcare: “Using painless, low-dose radiation that only goes skin deep to destroy cancer cells — without damaging health tissue” with Joseph C. Sardano, CEO of Sensus Healthcare, Inc.
As a part of my series about “The Future of Healthcare” I had the pleasure of interviewing Joseph C. Sardano, Chief Executive Officer, Sensus Healthcare Inc. A recognized leader in the healthcare industry, Joe Sardano has spent more than 30 years in management and marketing. He has a successful history of introducing and commercializing new […]
Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer
Medical Laser Pioneer and Veteran Entrepreneur Brings Over 30 Years of Experience to Company BOCA RATON, Fla., Feb. 28, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the Company has appointed Dr. Ziv Karni to the role […]
All about Keloid Scar Removal
Keloid scar removal is often an elusive task. This leaves many people living with unsightly scarring when the fact is they don’t need to! Here’s what you need to know about treating keloids most effectively. What Are Keloids? If you haven’t suffered from them, chances are that you have never heard of keloids. However, keloids […]
U.S. FDA Grants Market Clearance to Sensus Healthcare’s New Sculptura™ Radiation Oncology System
A Single Treatment during Surgery, Sculptura™ Eliminates Weeks of Post-Operative Radiation for Cancer Patients BOCA RATON, Fla., Feb. 26, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted market […]
Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth
Shipped 27 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radio Therapy to Treat Non-Melanoma Skin Cancers and Keloids
Published in The Journal of Clinical and Aesthetic Dermatology, Consensus was Reached that SRT is Safe, and Effective in Treating SCC and BCC and Should be Considered as the First-Line Form of Radiation Treatment. BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment […]
Modern Medicine – Dr. Brian Berman discusses the problem with keloids.
Researchers found in a retrospective study of 297 surgically excised keloids with superficial radiation therapy around the excision site that only 3% recurred during an average 6-month follow-up. Read the full article here.
Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare’s SRT-100™ for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities
Data from this Non-Invasive, Highly Effective Treatment Option for Non-Melanoma Skin Cancer Published in Journal of Drugs in Dermatology BOCA RATON, Fla., Feb. 12, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), announces the […]
Sensus Healthcare to Host Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call on February 14, 2019
BOCA RATON, Fla., Jan. 30, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, February 14, 2019 at 4:30 p.m. Eastern time to discuss the financial results […]
The Florida Sun – Orlando Surgeon Who Removes Keloids Is The First In Nation To Use The Latest Technology
Dr. Kenrick Spence, a Central Florida doctor, discusses the benefits of the SRT-100+ for keloid removal at Hilcrest Plastic Surgery in Orlando. With over 18 million people suffering from keloids, the market to remove the painful and itchy overgrowths of scars is highly in demand in this community. Read the full article here.
MedicalResearch.com – Dermatologist (Dr. Kristine A. Romine, MD) Discusses Personalized Approach to Skin Cancer Treatment
Dr. Kristine A. Romine, MD, CEO and Founder of Camelback Dermatology & Skin Surgery in Phoenix, AZ, explains the difference the personalized approach to skin cancer treatment that SRT provides to skin cancer patients. Read the full article here.
Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radio Therapy
SRT-100, a Low-energy X-ray Technology, Used at Site of Keloidectomy Treatment BOCA RATON, Fla., Dec. 6, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), announced today positive results of a multicenter case series of […]
Alternative Skin Cancer Treatments with SRT
It is very important to offer alternative skin cancer treatments within your practice. The difference between having to go under the knife or not to have skin cancer removed can make a very big difference in the life of a patient. This is especially true for the elderly patient that sometimes has to go through […]
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radio Therapy System for Treating Keloid Scars
Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), has installed its first SRT-100+ system at Hillcrest […]
8th Annual “New Frontiers in Cosmetic Medicine” (NFCM) Symposium
Join Sensus Healthcare at our Superficial Radio Therapy session taking place during the upcoming New Frontiers in Cosmetic Medicine (NFCM) Symposium on Sunday, November 18th. For more information click here, or to register click here.
Sensus Healthcare Third Quarter Financial Results Feature Revenue Growth of 32%
Shipped 18 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 1, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]